Thursday, September 14, 2017 10:15 PM ET
Insider Sales at USANA Health Sciences (USNA) Extends the Selling Trend of Last Quarter
SEC filings today reported substantial insider sales of USANA Health Sciences shares as two insiders — Myron W Wentz, Director, and Gull Global Ltd, 10% Owner — sold 158,588 shares in the company having a market value of approximately $9,136,529. There have been 2 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the sale of 240,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 398,588 shares and have averaged 99,647 shares per transaction over this time period.
The number of insider buy/sell trades at USANA Health Sciences is greater than that of the 16 peer company average over the last 90-day period. The Personal Products peer group saw 18 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by USANA Health Sciences insiders is lower than its peers. Within the peer group there were 3,199,695 shares purchased and 354,904 shares sold with company insiders having bought 258,617 shares on average over this time period.
The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* Myron W Wentz, Director, sold 79,294 shares
* Gull Global Ltd, 10% Owner, sold 79,294 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2017 UpTick Data Technologies. All rights reserved.